alpha-D-Glcp-(1->4)-[alpha-D-Glcp-(1->6)]-beta-D-Glcp

Term ID

CHEBI:147798

Synonyms

(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[[(2R,3S,4R,5R,6R)-4,5,6-trihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol
alpha-D-gluco-hexopyranosyl-(1->4)-[alpha-D-gluco-hexopyranosyl-(1->6)]-beta-D-gluco-hexopyranose
alpha-D-glucopyranosyl-(1->4)-[alpha-D-glucopyranosyl-(1->6)]-beta-D-glucopyranose
Glc(a1-4)[Glc(a1-6)]b-Glc

Definition

A α-D-Glcp-(1→4)-[α-D-Glcp-(1→6)]-D-Glcp which has β- configuration at the anomeric carbon.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-D-Glcp-(1->4)-[alpha-D-Glcp-(1->6)]-beta-D-Glcp

Phenotype where environments contain alpha-D-Glcp-(1->4)-[alpha-D-Glcp-(1->6)]-beta-D-Glcp

Phenotype modified by environments containing alpha-D-Glcp-(1->4)-[alpha-D-Glcp-(1->6)]-beta-D-Glcp

Phenotype affecting alpha-D-Glcp-(1->4)-[alpha-D-Glcp-(1->6)]-beta-D-Glcp

Human Disease Model